XLone-SOX7
(Plasmid
#163823)
-
Purposeexpresses human SOX7 upon doxycycline treatment
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 163823 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 | |
This material is available to academics and nonprofits only.
Backbone
-
Vector backboneXLone-GFP
-
Vector typeMammalian Expression
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSOX7
-
SpeciesH. sapiens (human)
-
Entrez GeneSOX7
- Promoter TRE3G
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Kpn1 (not destroyed)
- 3′ cloning site Spe1 (not destroyed)
- 5′ sequencing primer M13 FWD
- 3′ sequencing primer M13 REV (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
How to cite this plasmid
( Back to top)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
XLone-SOX7 was a gift from Xiaojun Lian (Addgene plasmid # 163823 ; http://n2t.net/addgene:163823 ; RRID:Addgene_163823) -
For your References section:
Direct programming of human pluripotent stem cells into endothelial progenitors with SOX17 and FGF2. Ream MW, Randolph LN, Jiang Y, Chang Y, Bao X, Lian XL. Stem Cell Reports. 2024 Mar 5:S2213-6711(24)00044-4. doi: 10.1016/j.stemcr.2024.02.006. 10.1016/j.stemcr.2024.02.006 PubMed 38518781
